Celiac disease is a serious autoimmune disease that occurs in genetically predisposed people where the ingestion of gluten leads to damage in the small intestine. It is estimated to affect 1 in 100 people worldwide, but only about 30% are properly diagnosed.
Investigators
Pfizer KAN-101
Enrolling: Yes
Principle Investigators: Monika Fischer, MD & Satya Kurada, MD
Duration: 56 weeks, 10 visits.
Patient Population: Adult Celiac patients with positive serology and intestinal histology.
Interested in this study? Please contact the IBD research team: iuibd@iu.edu
Closed Celiac Disease Studies
Duration: 32 weeks
Patient Population: Adult celiac patients with at lest 1 symptom, biopsy confirmed or blood test proving disease.
Study Intervention: Oral TAK-062